Home > Insider Trading > Filing (0001104659-25-060965)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1875558	Nuvectis Pharma Inc.	NVCT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1806384	Charles Marlio Mosseri	27 Ripplevale Grove London N1 1HS		No	No	Yes	No

Transaction Summary

Purchased:	33,442 shares	Avg. Price: $8.06	Total Value: $269,532.04
Number of Shares After Transactions:	2,976,203 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-06-17	5,399	$8.11	2,948,160	No	4	P	Indirect	By Emerald Hill Ventures SARL SPF.
Common Stock	Acquisiton	2025-06-18	28,043	$8.05	2,976,203	No	4	P	Indirect	By Emerald Hill Ventures SARL SPF.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Emerald Hill Ventures SARL SPF.
No	4	P	Indirect	By Emerald Hill Ventures SARL SPF.

Footnotes

Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.
Reflects the weighted average purchase price. The range of prices for the shares purchased was $7.91 to $8.11. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.